Diagnosis and treatment of prostate cancer with rectal cancer symptoms and literatures review

doi:10.3877/cma.j.issn.1674-3253.2022.02.018

Abstract

Abstract:

Objective

To investigate the diagnosis and treatment of prostate cancer with rectal cancer symptoms.

Methods

The data of 3 cases of prostate cancer with rectal cancer symptoms in our hospital were analyzed retrospectively.

Results

All 3 patients were admitted to the gastrointestinal department of our hospital due to gastrointestinal symptoms. Patient 2: digital rectal examination showed no abnormality, digital rectal examination was able to touch the mass in both patients 1 and 3. Both CT and MRI showed masses involving the prostate and rectum,colonoscopy showed a circumferential mass with a narrow lumen,the histology is high/low differentiated adenocarcinoma,all patients were initially diagnosed with rectal cancer.The patient 1 serum PSA:2.532 ng/ml, Miles surgery was performed, Gleason: 5+4=9 after surgery, immunohistochemistry: PSA/P504s (+), finally diagnosed as prostate cancer, and postoperative endocrine therapy was added.After urological consultation, serum PSA of patient 2 and patient 3 were >100 ng/ml and 153.49 ng/ml, Gleason scores were 5+3=8 and 4+3=7, respectively, and immunohistochemical PSA/P504s were (+). Finally, prostate cancer was diagnosed, and endocrine therapy and total pelvic organ resection were used for treatment.

Conclusion

The diagnosis of prostate cancer should be combined with medical history, various examinations, histology and immunohistochemistry, and avoided wrong treatment.

Key words: Rectal cancer, Prostate cancer, Misdiagnosis, Metastasis

Jiayu Huang, Qiang Huang, Dejuan Wang, Bo Ma, Hu Qu, Bing Yao, Wenwen Zhong, Lei Ye, Qiang Guo, Lei Wang, Jianjian Wu, Jianguang Qiu, Zhongyang Wang. Diagnosis and treatment of prostate cancer with rectal cancer symptoms and literatures review[J]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(02): 177-180.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjmnmwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3253.2022.02.018

https://zhqjmnmwkzz.cma-cmc.com.cn/EN/Y2022/V16/I02/177

Figures/Tables 1

References 23

[1]	David JB, Mark IO, Peter JB. Rectal infiltration by prostatic adenocarcinoma: report on six patients and review of the literature[J].Ann R Coll Surg Engl, 2003, 85(6): 382-385.
[2]	Imamura T, Shimaoka S, Tashiro K, et al. Two cases of circumferential rectal invasion from prostatic cancer[J]. Nihon Shokakibyo Gakkai Zasshi, 2012, 109(3): 425-434.
[3]	Villers A, Mcneal JE, Freiha FS, et al. Invasion of denonvilliers' fascia in radical prostatectomy specimens[J]. J Urol, 1993, 149(4): 793-798.
[4]	Murray SK, Breau RH, Guha AK, et al. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma[J]. Am J Surg Pathol, 2004, 28(9): 1154-1162.
[5]	Vaghefi H, Magi-Galluzzi C, Klein EA. Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomy[J]. Urology, 2005, 66(4): 881.
[6]	Lane Zhaoli, Jonathan IE, Salman A, et al. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features[J]. Human Pathol, 2008, 39(4): 543-549.
[7]	Lazarus JA. Complete rectal occlusion necessitating colostomy due to carcinoma of the prostate[J]. Am J Surg, 1935, 30(3): 502-505.
[8]	Winter CC. The problem of rectal involvement by prostatic cancer[J]. Surg Gynecol Obstet, 1957, 105(2): 136-40.
[9]	Fry DE, Amin M, Harbrecht PJ. Rectal obstruction secondary to carcinoma of the prostate[J]. Ann Surg, 1979, 189(4): 488-492.
[10]	Lea D, H?Land S, Hagland HR, et al. Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era[J]. Scand J Gastroenterol, 2014, 49(10): 1153-1163.
[11]	Mitrovic B, Schaeffer DF, Riddell RH, et al. Tumor budding in colorectal carcinoma: time to take notice[J]. Mod Pathol, 2012, 25(10): 1315-1325.
[12]	Tang T, Yang Z, Zhang D, et al. Clinicopathological study of 9 cases of prostate cancer involving the rectal wall[J]. Diagn Pathol, 2017, 12(1): 8.
[13]	Varma M, Lee MW, Tamboli P, et al. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice[J]. Arch Pathol Lab Med, 2002, 126(5): 554-561.
[14]	ZhiHua Liu, Chao Li, Liang Kang, et al. Prostate cancer incorrectly diagnosed as a rectal tumor: A case report[J]. Oncol Lett, 2015, 9(6): 2647-2650.
[15]	Carswell BM, Woda BA, Wang X, et al. Detection of prostate cancer by α-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy[J]. Histopathology, 2010, 48(6): 668-673.
[16]	Jiang Z, Wu CL, Woda BA, et al. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy[J]. Am J Surg Pathol, 2002, 26(9): 1169-1174.
[17]	Gallee MPW, Jong VD, Korput JAVD, et al. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens[J]. Urol Res, 1990, 18(3): 181-187.
[18]	Bassily NH, Vallorosi CJ, Güliz Akdas, et al. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma[J]. Am J Clin Pathol,113(3):83-388.
[19]	Berezowski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma[J]. Mod Pathol, 1996, 9(4):426-429.
[20]	Lagendijk JH, Mullink H, Van Diest PJ, et al. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites[J]. Hum Pathol, 1998, 29(5): 491-497.
[21]	Kaimaktchiev V, Terracciano L, Tornillo L, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas[J]. Mod Pathol, 2004, 17(11): 1392-1399.
[22]	Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas[J]. Am J Surg Pathol, 2003, 27(3): 303-310.
[23]	Osunkoya AO, Netto GJ, Epstein JI. Colorectal adenocarcinoma involving the prostate: report of 9 cases[J]. Hum Pathol, 2007, 38(12): 1836-1841.

Please choose a citation manager

Content to export